Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Spiny mice can regenerate damaged kidneys without fibrosis

Nov. 10, 2021

Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor

Nov. 10, 2021

Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis

Nov. 10, 2021

IL-33, a potential new therapeutic target for diabetic kidney disease

Nov. 10, 2021

New mouse model allows investigation of EP3 receptor function in the kidney tubule

Nov. 10, 2021

ADX-097 displays targeted complement inhibition in tissues

Nov. 9, 2021

L-WNK1 inhibition as novel therapeutic strategy for protection from glomerular injury

Nov. 9, 2021

Novel small molecule K+ secretagogue RDX-013 for treating hyperkalemia

Nov. 8, 2021

Novel UOX-iKO mouse as model of hyperuricemia

Nov. 8, 2021

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Nov. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....